Randomised, Double-blind, Comparative Clinical Study of New Ranibizumab Biosimilar in Neovascular (Wet) Age-Related Macular Degeneration

por Apsangikar, Prasad, Ghadge, Pravin, Naik, Manoj, Nair, Santosh, Payghan, Ravikiran
Publicado 2021

Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease

por Kanter, Julie, Brown, R. Clark, Norris, Cynthia, Nair, Santosh M., Kutlar, Abdullah, Manwani, Deepa, Shah, Nirmish, Tanaka, Chiaki, Bodla, Shankaranand, Sanchez-Olle, Gessami, Albers, Urs, Liles, Darla
Publicado 2022

Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study

por Haverkos, Bradley, Alpdogan, Onder, Baiocchi, Robert, Brammer, Jonathan E., Feldman, Tatyana A., Capra, Marcelo, Brem, Elizabeth A., Nair, Santosh, Scheinberg, Phillip, Pereira, Juliana, Shune, Leyla, Joffe, Erel, Young, Patricia, Spruill, Susan, Katkov, Afton, McRae, Robert, Royston, Ivor, Faller, Douglas V., Rojkjaer, Lisa, Porcu, Pierluigi
Publicado 2023